Testing New PET/MRI Scan in Large DCIS
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with ductal carcinoma in situ (DCIS), a very early form of breast cancer.
- The DCIS area is larger than about 4 cm (1.6 inches) on mammogram, MRI, or ultrasound.
- You are planning to have the DCIS removed with surgery (lumpectomy or mastectomy).
- You are not pregnant, nursing, or less than 8 weeks past pregnancy or nursing.
- You have no metal implants or severe claustrophobia that would prevent an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
This study tests a new imaging method using a special tracer and PET/MRI scans to better see breast cancer. It may help doctors plan your treatment more precisely.
This trial tests a new imaging scan that combines a special PET tracer with MRI to help guide a prostate biopsy. The goal is to see if this scan can more accurately find cancer and reduce the need for extra biopsies.
This early-phase study looks at how well PET/MRI scans can monitor treatment response in people with HER2-positive breast cancer before surgery. You may be asked to undergo specific scans during “neoadjuvant” therapy (treatment given before the main operation).
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
Hear when a new Carcinoma, Intraductal, Noninfiltrating trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.